Joe Ciaffoni
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Joe Ciaffoni
Joe Ciaffoni is recorded as CEO at Collegium Pharmaceutical, Inc (COLL) and CEO and Board Member at Indivior Pharmaceuticals, Inc. (INDV). Indivior Pharmaceuticals, Inc. reported in an 8-K filed May 8, 2025 that Joe Ciaffoni was appointed CEO, effective May 8, 2025. Indivior Pharmaceuticals, Inc. reported in an 8-K filed March 4, 2025 that Joe Ciaffoni was appointed Chief Executive Officer. The proxy statement of Indivior Pharmaceuticals, Inc. reports total compensation of $18,501,214 for Joe Ciaffoni in fiscal 2025, including a base salary of $680,114. Joe Ciaffoni has spoken on 10 earnings calls and 1 other investor event across 2 companies, most recently for Indivior Pharmaceuticals, Inc. on June 3, 2026.
“Following shareholder approval of the Company’s Directors’ Remuneration Policy, the Company and Joe Ciaffoni agreed that his employment as CEO would commence on May 8, 2025.”
“Previously, Indivior PLC announced that it had appointed Joe Ciaffoni, currently an Independent Non-Executive Director of the Company, as Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-01-23–present
-
Current
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2026-01-23–present
Leadership on record at Collegium Pharmaceutical, Inc
Other people whose current roles at this company are on record from its filings.
- Gino Santini Chairman, Board Member
- David Dieter General Counsel
- Shirley Kuhlmann General Counsel
- Carlos Paya Board Member
- Dr. Rita Balice-Gordon, Ph.D. Board Member
- Garen Bohlin Board Member
- John Fallon Board Member
- John Freund Board Member
- Joseph Ciaffoni Board Member
- Nancy Lurker Board Member
Leadership on record at Indivior Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Ryan Preblick CFO
- Barbara Ryan Board Member
- Daniel Ninivaggi Board Member
- Dr. David Wheadon Board Member
- Dr. Keith Humphreys Board Member
- Joseph Ciaffoni Board Member
- Juliet Thompson Board Member
- Mark Stejbach Board Member
- Stuart A. (Tony) Kingsley Board Member
- Tony Kingsley Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Indivior Pharmaceuticals, Inc. (INDV) | Chief Executive Officer | $680,114 | $18,501,214 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.